Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Document › Details

Novartis AG. (7/18/17). "Press Release: Q2 Results Confirm Full Year Guidance". Basel.

	Organisation	Novartis AG (NYSE: NVS)
	Group	Novartis (Group)
	Organisation 2	Sandoz (division of Novartis)
	Group	Novartis (Group)
	Product	pharmaceutical
	Product 2	DRUGS, BIOGEN, GENERICS (biosimilars / biogenerics)
	Person	Jimenez, Joseph (Joe) (Novartis 201002–CEO before since 200704 CEO Consumer Health)

Original document
accessed by [iito] on 2017-07-18

Record changed: 2023-06-05

Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Novartis (Group)

[1] Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel....
[2] Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge....
[3] Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel....
[4] BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam....
[5] Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel....
[6] Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel....
[7] Galapagos N.V.. (6/12/23). "Pressemitteilung: Galapagos Appoints Dr. Susanne Schaffert as Non-executive Independent Director to Its Board". Mechelen....
[8] AvroBio, Inc.. (5/22/23). "Press Release: AvroBio Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million". Cambridge, MA....
[9] Evotec SE. (5/9/23). "Press Release: Just – Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing". Hamburg & Seattle, WA....
[10] 3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]